N- (dibenzo (b, f) oxepin-10-ylmethyl) N-methyl-N-prop-2-ynylamine (Omigapyr) for prevention and / or treatment of congenital muscular dystrophy or myopathy caused by type VI collagen deficiency Usage

摘要

The invention relates to the use of a compound of the formula (I) or a pharmaceutically acceptable addition salt thereof for the preparation of a medicament for the prophylaxis and/or treatment of muscular dystrophies or myopathies resulting from mutations in genes encoding for collagen VI.